英文名稱 Anti-CCL19/MIP-3 beta

中文名稱 巨噬細(xì)胞炎性蛋白19抗體

濃 度 1mg/1ml

規(guī) 格 0.2ml/200μg

抗體來源 Rabbit

交叉反應(yīng) Human, Mouse, Rat, Pig

產(chǎn)品類型 一抗

研究領(lǐng)域 細(xì)胞生物 免疫學(xué) 自然殺傷細(xì)胞

蛋白分子量 predicted molecular weight: 9.2kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from mouseCCL19

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 Macrophage Inflammatory Protein 3β; Beta chemokine exodus 3; C C chemokine ligand 19; CC chemokineligand 19; CCL19; Chemokine (C C motif) ligand 19; Chemokine (CC motif) ligand19; Chemokine CC Motif Ligand 19; CK beta 11; CKb11; EBI1 ligand chemokine;ELC; Exodus 3; MGC34433; MIP 3 beta; MIP3 beta; MIP3B; OTTHUMP00000000531;SCYA19; Small inducible cytokine A19; CCL19_MOUSE.